Search research articles
Contact Us
Filters
Showing results (171-180 of 560) with videos related to
Page
of 56
Sort By:
Gynecologic Oncology
|
March 26, 2010
Serum biomarker panels for the discrimination of benign from malignant cases in patients with an adnexal mass
Brian Nolen, Liudmila Velikokhatnaya, Adele Marrangoni, et al.
Lasers in Surgery and Medicine
|
September 13, 2001
Fluorescence spectroscopy for in vivo characterization of ovarian tissue
M Brewer, U Utzinger, E Silva, et al.
The Journal of Clinical Investigation
|
November 1, 1981
Reactivity of a monoclonal antibody with human ovarian carcinoma
R C Bast, M Feeney, H Lazarus, et al.
Oncogene
|
December 22, 1999
Regulation of BAD phosphorylation at serine 112 by the Ras-mitogen-activated protein kinase pathway
X Fang, S Yu, A Eder, et al.
Cancer Letters
|
August 21, 2012
Paclitaxel inhibits ovarian tumor growth by inducing epithelial cancer cells to benign fibroblast-like cells
Lizhou Jia, Shiwu Zhang, Yanfen Ye, et al.
Journal of the National Cancer Institute
|
August 1, 1974
Presence of A-type and absence of C-type virus particles in a chemically induced guinea pig hepatoma
V C Dunkel, R C Bast, B I Gerwin, et al.
The International Journal of Biological Markers
|
May 6, 1999
CA 125: the past and the future
R C Bast, F J Xu, Y H Yu, et al.
Gynecologic Oncology
|
February 13, 2001
Synergistic interaction between an anti-p185HER-2 pseudomonas exotoxin fusion protein [scFv(FRP5)-ETA] and ionizing radiation for inhibiting growth of ovarian cancer cells that overexpress HER-2
M Schmidt, A McWatters, R A White, et al.
Obstetrics and Gynecology
|
January 1, 1994
Mutation and overexpression of the p53 tumor suppressor gene frequently occurs in uterine and ovarian sarcomas
F S Liu, M F Kohler, J R Marks, et al.
Obstetrics and Gynecology
|
February 1, 1990
The role of peptide growth factors in epithelial ovarian cancer
A Berchuck, G J Olt, L Everitt, et al.
Page
of 56
Search research articles
Search
Showing results (171-180 of 560) with videos related to
Sort By:
Page
of 56
Gynecologic Oncology
|
March 26, 2010
Serum biomarker panels for the discrimination of benign from malignant cases in patients with an adnexal mass
Brian Nolen, Liudmila Velikokhatnaya, Adele Marrangoni, et al.
Lasers in Surgery and Medicine
|
September 13, 2001
Fluorescence spectroscopy for in vivo characterization of ovarian tissue
M Brewer, U Utzinger, E Silva, et al.
The Journal of Clinical Investigation
|
November 1, 1981
Reactivity of a monoclonal antibody with human ovarian carcinoma
R C Bast, M Feeney, H Lazarus, et al.
Oncogene
|
December 22, 1999
Regulation of BAD phosphorylation at serine 112 by the Ras-mitogen-activated protein kinase pathway
X Fang, S Yu, A Eder, et al.
Cancer Letters
|
August 21, 2012
Paclitaxel inhibits ovarian tumor growth by inducing epithelial cancer cells to benign fibroblast-like cells
Lizhou Jia, Shiwu Zhang, Yanfen Ye, et al.
Journal of the National Cancer Institute
|
August 1, 1974
Presence of A-type and absence of C-type virus particles in a chemically induced guinea pig hepatoma
V C Dunkel, R C Bast, B I Gerwin, et al.
The International Journal of Biological Markers
|
May 6, 1999
CA 125: the past and the future
R C Bast, F J Xu, Y H Yu, et al.
Gynecologic Oncology
|
February 13, 2001
Synergistic interaction between an anti-p185HER-2 pseudomonas exotoxin fusion protein [scFv(FRP5)-ETA] and ionizing radiation for inhibiting growth of ovarian cancer cells that overexpress HER-2
M Schmidt, A McWatters, R A White, et al.
Obstetrics and Gynecology
|
January 1, 1994
Mutation and overexpression of the p53 tumor suppressor gene frequently occurs in uterine and ovarian sarcomas
F S Liu, M F Kohler, J R Marks, et al.
Obstetrics and Gynecology
|
February 1, 1990
The role of peptide growth factors in epithelial ovarian cancer
A Berchuck, G J Olt, L Everitt, et al.
Page
of 56